7,580.07

-140.32

-1.82%

51,770.31

-572.25

-1.09%

25,437.00

-747.73

-2.86%

2,811.84

-47.37

-1.66%

4.9290

-0.0600

-1.20%

19.42

+2.22

+12.91%

3,898.90

-132.50

-3.29%

77,874.24

+599.17

+0.78%

Crude Oil Dec 26

104.12

+2.12

+2.08%

US Private Equity

10,850.63

-82.20

-0.75%

NasdaqGM - Delayed Quote USD

Alvotech (ALVOW)

0.2436 +0.0636 (+35.33%)

At close: October 30 at 11:38:01 AM EDT

Alvotech to Report Financial Results for the Nine-Month Period to September 30, 2026

GlobeNewswire 4d ago

ALVO

ALVO-SDB

ALVO.SDB
Alvotech to Report Financial Results for the Nine-Month Period to September 30, 2026

GlobeNewswire 4d ago

ALVO

ALVO-SDB

ALVO.SDB
Repligen (RGEN) Q3 Earnings and Revenues Surpass Estimates

Zacks 5d ago

RGEN

ALVO
New Strong Sell Stocks for October 21st

Zacks 11d ago

NG=F

CSIQ

ALVO
New Strong Sell Stocks for October 20th

Zacks 11d ago

NG=F

CSIQ

ALVO
Alvotech's Manufacturing Progress, Simponi Launch Potential Support Recovery, UBS Says

PREMIUM
MT Newswires 11d ago

ALVO

TEVA

JNJ
Alvotech shares jump premarket after FDA approves new Simlandi process

Investing.com 12d ago

ALVO
Alvotech receives FDA approval for new SIMLANDI® manufacturing process that more than doubles output per batch

GlobeNewswire 12d ago

ALVO

ALVO-SDB

ALVO.SDB
Alvotech Receives FDA Approval for New SIMLANDI® Manufacturing Process That More Than Doubles Output Per Batch

GlobeNewswire 12d ago

ALVO

ALVO-SDB

ALVO.SDB
Alvotech Stock In Focus After Europe Filing For Eylea 8 Mg Copycat

Simply Wall St. 15d ago

ALVO
Alvotech and Advanz Pharma announce first known regulatory submission worldwide for proposed biosimilar to Eylea® 8 mg

GlobeNewswire 18d ago

ALVO

ALVO-SDB

ALVO.SDB
Alvotech and Advanz Pharma announce first known regulatory submission worldwide for proposed biosimilar to Eylea® 8 mg

GlobeNewswire 18d ago

ALVO

ALVO-SDB

ALVO.SDB

Mobilize your Website

View Site in Mobile | Classic

Share by: